Cresco Labs Inc.
CRLBF- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001832928
No open-market purchases or sales by Cresco Labs Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $122.7K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Cresco Labs Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 13 | 16 | +3 |
| Shares | 569.8K | 587.8K | +18.1K (+3.2%) |
| Value | $3.79M | $3.54M | −$259.4K (−6.8%) |
New holders (3)
Institutions that held Cresco Labs Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Carter Financial Group, INC. | 21,805 | $131.0K | 0.18% |
| Bartlett & Co. LLC | 1,605 | $10.0K | 0.00% |
| Bartlett & Co. Wealth Management LLC | 1,605 | $9.64K | 0.00% |
Sold out (0)
Institutions that held Cresco Labs Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
None.